Literature DB >> 19888203

Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis.

Gail M Kephart1, Jeffrey A Alexander, Amindra S Arora, Yvonne Romero, Thomas C Smyrk, Nicholas J Talley, Hirohito Kita.   

Abstract

OBJECTIVES: Eosinophilic esophagitis (EoE) is characterized by infiltration of eosinophils into esophageal epithelium. Blood levels of an eosinophil granule protein, eosinophil-derived neurotoxin (EDN), have been proposed as a biomarker for EoE. However, information regarding localization of EDN in the diseased tissues has not been available. The goal of this study was to evaluate the magnitude and distribution of EDN deposition in tissue specimens from the esophagus of EoE patients.
METHODS: We studied specimens from 10 adult EoE patients and eight histologically normal controls (three under age 17). Sections from mid-esophageal biopsy specimens were stained for EDN by immunofluorescence, using a polyclonal rabbit antibody to EDN. Cellular staining (i.e., infiltration of intact eosinophils) and extracellular staining (i.e., deposition of released EDN) were scored in a blinded manner on an established 7-point scale.
RESULTS: Esophageal biopsy specimens from histologically normal controls showed no or few intact eosinophils and no or minimal extracellular EDN deposition. In contrast, EDN staining was clearly observed in specimens from all EoE patients. In some EoE patients, marked extracellular EDN deposition was observed despite relatively small numbers of intact eosinophils. Overall, there was no correlation between the eosinophil infiltration and the extracellular EDN staining scores.
CONCLUSIONS: Marked tissue deposition of extracellular EDN is present in the esophagus of EoE patients. Tissue eosinophil counts may underestimate how extensively eosinophils are involved, particularly in individuals with marked eosinophil degranulation. Evaluation of EDN staining in esophageal biopsy specimens may be useful to diagnose and manage patients with EoE.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19888203      PMCID: PMC2824254          DOI: 10.1038/ajg.2009.584

Source DB:  PubMed          Journal:  Am J Gastroenterol        ISSN: 0002-9270            Impact factor:   10.864


  32 in total

Review 1.  Mechanisms of eosinophil-associated inflammation.

Authors:  G J Gleich
Journal:  J Allergy Clin Immunol       Date:  2000-04       Impact factor: 10.793

2.  Deposition of eosinophil granule major basic protein in eosinophilic gastroenteritis and celiac disease.

Authors:  N J Talley; G M Kephart; T W McGovern; H A Carpenter; G J Gleich
Journal:  Gastroenterology       Date:  1992-07       Impact factor: 22.682

3.  Dermal deposition of eosinophil-granule major basic protein in atopic dermatitis. Comparison with onchocerciasis.

Authors:  K M Leiferman; S J Ackerman; H A Sampson; H S Haugen; P Y Venencie; G J Gleich
Journal:  N Engl J Med       Date:  1985-08-01       Impact factor: 91.245

4.  An immunofluorescent method for specific staining of eosinophil granule major basic protein.

Authors:  W V Filley; S J Ackerman; G J Gleich
Journal:  J Immunol Methods       Date:  1981       Impact factor: 2.303

5.  Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy.

Authors:  M S Peters; M Rodriguez; G J Gleich
Journal:  Lab Invest       Date:  1986-06       Impact factor: 5.662

6.  Identification by immunofluorescence of eosinophil granule major basic protein in lung tissues of patients with bronchial asthma.

Authors:  W V Filley; K E Holley; G M Kephart; G J Gleich
Journal:  Lancet       Date:  1982-07-03       Impact factor: 79.321

7.  IgA-induced eosinophil degranulation.

Authors:  R I Abu-Ghazaleh; T Fujisawa; J Mestecky; R A Kyle; G J Gleich
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

8.  Anti-IL-5 (mepolizumab) therapy reduces eosinophil activation ex vivo and increases IL-5 and IL-5 receptor levels.

Authors:  Miguel L Stein; Joyce M Villanueva; Bridget K Buckmeier; Yoshiyuki Yamada; Alexandra H Filipovich; Amal H Assa'ad; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2008-04-14       Impact factor: 10.793

9.  Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome.

Authors:  S E Attwood; T C Smyrk; T R Demeester; J B Jones
Journal:  Dig Dis Sci       Date:  1993-01       Impact factor: 3.199

10.  Biochemical and functional similarities between human eosinophil-derived neurotoxin and eosinophil cationic protein: homology with ribonuclease.

Authors:  G J Gleich; D A Loegering; M P Bell; J L Checkel; S J Ackerman; D J McKean
Journal:  Proc Natl Acad Sci U S A       Date:  1986-05       Impact factor: 11.205

View more
  37 in total

Review 1.  Diagnosis and management of eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Clin Gastroenterol Hepatol       Date:  2012-06-19       Impact factor: 11.382

2.  Diagnostic utility of major basic protein, eotaxin-3, and leukotriene enzyme staining in eosinophilic esophagitis.

Authors:  Evan S Dellon; Xiaoxin Chen; C Ryan Miller; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2012-07-10       Impact factor: 10.864

3.  Extracellular Eosinophil Granule Protein Deposition in Ringed Esophagus with Sparse Eosinophils.

Authors:  Kathryn A Peterson; William J Cobell; Frederic C Clayton; Chaya Krishnamurthy; Jian Ying; Leonard F Pease; Hedieh Saffari; Ann Georgelas; John Fang; Gerald J Gleich; Kristin M Leiferman
Journal:  Dig Dis Sci       Date:  2015-04-23       Impact factor: 3.199

Review 4.  Eosinophilic Vasculitis.

Authors:  Karen L Vega Villanueva; Luis R Espinoza
Journal:  Curr Rheumatol Rep       Date:  2020-01-11       Impact factor: 4.592

Review 5.  Advances in clinical management of eosinophilic esophagitis.

Authors:  Evan S Dellon; Chris A Liacouras
Journal:  Gastroenterology       Date:  2014-08-07       Impact factor: 22.682

6.  Utility of a Noninvasive Serum Biomarker Panel for Diagnosis and Monitoring of Eosinophilic Esophagitis: A Prospective Study.

Authors:  Evan S Dellon; Spencer Rusin; Jessica H Gebhart; Shannon Covey; Leana L Higgins; RoseMary Beitia; Olga Speck; Kimberly Woodward; John T Woosley; Nicholas J Shaheen
Journal:  Am J Gastroenterol       Date:  2015-03-17       Impact factor: 10.864

7.  Effect of proton pump inhibitor on esophageal eosinophilia.

Authors:  Shauna Schroeder; Kelley E Capocelli; Joanne C Masterson; Rachel Harris; Cheryl Protheroe; James J Lee; Glenn T Furuta
Journal:  J Pediatr Gastroenterol Nutr       Date:  2013-02       Impact factor: 2.839

Review 8.  Eosinophilic esophagitis.

Authors:  Evan S Dellon
Journal:  Gastroenterol Clin North Am       Date:  2012-12-27       Impact factor: 3.806

Review 9.  New Developments in the Diagnosis and Treatment of Eosinophilic Esophagitis.

Authors:  Quan M Nhu; Fouad J Moawad
Journal:  Curr Treat Options Gastroenterol       Date:  2019-03

10.  Marked deposition of eosinophil-derived neurotoxin in adult patients with eosinophilic esophagitis (am j gastroenterol 2010;105:298-307).

Authors:  Yunju Jo
Journal:  J Neurogastroenterol Motil       Date:  2010-10-30       Impact factor: 4.924

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.